Inhibition of constitutive activity of nuclear transcription factor kappaB sensitizes doxorubicin-resistant cells to apoptosis.
about
Overexpression of angiopoietin-1 reduces doxorubicin-induced apoptosis in cardiomyocytesAddressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicinImatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenolsRas puts the brake on doxorubicin-mediated cell death in p53-expressing cellsHSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer.Ganetespib for small cell lung cancer.Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL.HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells.Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor.A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer.
P2860
Q28395625-6B9A9D35-9096-47FF-B5CD-41CBE4CDF4FCQ28476078-069A48FD-6BC0-4AD9-8C07-067A0A8FA898Q28485861-79462092-A526-4E6B-9B6C-E5C94135DBE5Q33864180-A4B0124B-A1D6-4EE2-AD4D-ADB715F14C99Q34606299-0C1C7443-0C15-4146-B66D-DE06E9D2604BQ37728631-C4CE4808-C041-41D4-950E-E354074C9014Q38786678-69F26D5B-AC48-4724-BE7F-1EC31B49667DQ38911672-A540BE15-B239-4298-B5D9-7F6C0814950CQ39397750-A4A5D9E8-5976-4C41-9B69-932BE7818395Q39703528-9A99C6F5-786C-4466-9B3D-52AF6C5707CBQ39817767-8B5303B6-2D74-4439-B10E-9A291FE4264DQ42385396-31E04807-463C-4C74-A5F0-6DC779397772Q44093032-AE6CDB08-5F38-4885-85B6-71A16BA1DA37Q55081754-179F7EF1-B875-4864-915C-7C5811AEAEE6
P2860
Inhibition of constitutive activity of nuclear transcription factor kappaB sensitizes doxorubicin-resistant cells to apoptosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@en
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@nl
type
label
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@en
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@nl
prefLabel
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@en
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@nl
P2093
P2860
P356
P1476
Inhibition of constitutive act ...... -resistant cells to apoptosis.
@en
P2093
Charitha Gangadharan
Maikho Thoh
Sunil K Manna
P2860
P304
P356
10.1002/JCB.22115
P577
2009-05-01T00:00:00Z